A citation-based method for searching scientific literature

W E Wright, M A Piatyszek, W E Rainey, W Byrd, J W Shay. Dev Genet 1996
Times Cited: 947



Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
Times Cited: 1092




List of shared articles



Times cited

Cancer-associated POT1 mutations lead to telomere elongation without induction of a DNA damage response.
Won-Tae Kim, Kelsey Hennick, Joshua Johnson, Brendan Finnerty, Seunga Choo, Sarah B Short, Casey Drubin, Ryan Forster, Mary L McMaster, Dirk Hockemeyer. EMBO J 2021
1

The Jekyll and Hyde of Cellular Senescence in Cancer.
Dilara Demirci, Bengisu Dayanc, Fatma Aybuke Mazi, Serif Senturk. Cells 2021
2

Shelterin complex gene: Prognosis and therapeutic vulnerability in cancer.
Vikas Kumar Bhari, Durgesh Kumar, Surendra Kumar, Rajeev Mishra. Biochem Biophys Rep 2021
0

Genomic footprints of activated telomere maintenance mechanisms in cancer.
Lina Sieverling, Chen Hong, Sandra D Koser, Philip Ginsbach, Kortine Kleinheinz, Barbara Hutter, Delia M Braun, Isidro Cortés-Ciriano, Ruibin Xi, Rolf Kabbe,[...]. Nat Commun 2020
21

Regulation of human telomerase in homeostasis and disease.
Caitlin M Roake, Steven E Artandi. Nat Rev Mol Cell Biol 2020
42

Telomeres and Telomerase in the Development of Liver Cancer.
Lena In der Stroth, Umesh Tharehalli, Cagatay Günes, André Lechel. Cancers (Basel) 2020
6

TINF2 is a haploinsufficient tumor suppressor that limits telomere length.
Isabelle Schmutz, Arjen R Mensenkamp, Kaori K Takai, Maaike Haadsma, Liesbeth Spruijt, Richarda M de Voer, Seunga Sara Choo, Franziska K Lorbeer, Emma J van Grinsven, Dirk Hockemeyer,[...]. Elife 2020
2


The Solo Play of TERT Promoter Mutations.
François Hafezi, Danielle Perez Bercoff. Cells 2020
7

Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers.
Josh Lewis Stern, Grace Hibshman, Kevin Hu, Sarah E Ferrara, James C Costello, William Kim, Pablo Tamayo, Thomas R Cech, Franklin W Huang. Mol Cancer Res 2020
6


Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
167

Telomere Maintenance in Pediatric Cancer.
Sandra Ackermann, Matthias Fischer. Int J Mol Sci 2019
1

Cancer therapy with a CRISPR-assisted telomerase-activating gene expression system.
Wei Dai, Xinhui Xu, Danyang Wang, Jian Wu, Jinke Wang. Oncogene 2019
10

Diverse regulatory manners of human telomerase reverse transcriptase.
Meng-Meng Jie, Xing Chang, Shuo Zeng, Cheng Liu, Guo-Bin Liao, Ya-Ran Wu, Chun-Hua Liu, Chang-Jiang Hu, Shi-Ming Yang, Xin-Zhe Li. Cell Commun Signal 2019
8

MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer.
Javier A Baena-Del Valle, Qizhi Zheng, David M Esopi, Michael Rubenstein, Gretchen K Hubbard, Maria C Moncaliano, Andrew Hruszkewycz, Ajay Vaghasia, Srinivasan Yegnasubramanian, Sarah J Wheelan,[...]. J Pathol 2018
23